期刊文献+

肿瘤标志物联合检测及评分模型在肿瘤诊疗中的应用 被引量:13

The application and prospect for the tumor marker score model in clinical diagnosis and therapy
原文传递
导出
摘要 由于单个肿瘤标志物的敏感性和特异性常不够理想,因此合理选择肿瘤标志物进行有机组合,并利用模糊数学原理建立相应的评分预测模型在临床肿瘤诊疗中有重要的应用价值。多项大数据研究结果显示,肿瘤标志物的组合及评分模型可以为肿瘤患者提供更为有效和准确的个体化信息,从而有助于临床制定个体化治疗方案、监测疗效及判断预后。应用合理高效的肿瘤标志物评分模型将为肿瘤患者的诊疗提供新的思路和方法。(中华检验医学杂志,2018, 41:180-184) Single tumor marker (TM) for cancer diagnosis with both satisfactory sensitivity and specificity has not been found. Therefore, it is necessary to identify the biomarkers to make the TM panel and establish the corresponding multiparameter predictive model through fuzzy mathematics methods. Recent studies using the big data technology showed that the integration of the biomarkers panel and prediction score model could provide the effective and accurate diagnosis for the cancer patients and be in favor of making the scheme for personalized therapy, treatment-monitoring and prognosis prediction. A reliable and efficient TM score prediction model will provide the novel perspectives and procedures for the diagnosis and treatment of cancer patients.(Chin J Lab Med, 2018, 41: 180-184)
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2018年第3期180-184,共5页 Chinese Journal of Laboratory Medicine
基金 国家自然科学基金资助项目(81772808,81572552,81772774) 上海市科委资助项目(KW17411963500) 上海市申康医院发展中心项目(SHDC22014002)
关键词 肿瘤标志物 恶性肿瘤 多参数评分模型 风险评估 Tumor marker Neoplasm Multiparameter score model Risk prediction
  • 相关文献

参考文献8

二级参考文献61

  • 1陈允硕,吴健民.肿瘤标志物临床检测的基本原则(建议稿)[J].中华检验医学杂志,2004,27(6):393-393. 被引量:35
  • 2吴荣,迟峰.结直肠癌术后局部复发或转移的三维适形放疗[J].中华放射肿瘤学杂志,2005,14(4):302-303. 被引量:14
  • 3叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:119
  • 4季加孚,武爱文.进展期胃癌新辅助化疗的研究进展[J].中华胃肠外科杂志,2007,10(4):394-395. 被引量:58
  • 5Wang CS,Chao TC,Jan YY,et al.Benefits of palliative surgery for far-advanced gastric cancer.Chang Gung Med J,2002,25 (12):792-802.
  • 6Washington K.7th edition of the AJCC cancer staging manual:stomach.Ann Surg Oncol,2010,17(12):3077-3079.
  • 7Takahashi Y,Takeuchi T,Sakamoto J,et al.The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients:a prospective clinical study.Gastric Cancer,2003,6(3):142-145.
  • 8Cidón EU,Bustamante R.Gastric cancer:tumor markers as predictive factors for preoperative staging.J Gastrointest Cancer,2010,42(3):127- 130.
  • 9Hwang GI, Yoo CH, Sohn BH, et al.Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma.Cancer Res Treat,2004,36(3):178-181.
  • 10Mattar R,Alves DAC,Difavero GM,et al.Preoperative serum levels of CA72 -4, CEA, CA19-9, and alpha- fetoprotein in patients with gastric cancer.Rev Hosp Clin Fac Med Sao Paulo,2002,57 (3):89-92.

共引文献250

同被引文献110

引证文献13

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部